Beta
82380

Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

Internal Medicine

Abstract

Background: Hepatocellular carcinoma [HCC] is one of the leading causes of cancer-related deaths worldwide. A major problem with HCC surveillance is the lack of reliable biomarkers. Serum transthyretin [TTR] may be a sensitive marker for the diagnosis of patients with liver cell damage, liver cirrhosis or hepatocellular carcinoma. 
Aim of the work: This study aimed to evaluate the potentiality of serum transthyretin [TTR] as a novel biomarker for detection of HCC in cirrhotic patients.
Patients and Methods:This Current study was conducted on 70 patients with chronic liver disease. Also, 20 healthy person matched for age and sex were included as a control group. Patients were classified into 2 groups [30 cirrhotic patients with newly diagnosed HCC & 40 cirrhotic patients without HCC]. Serum TTR levels were measured using enzyme linked immunosorbent assay technique.
Results: Serum levels of TTR were significantly much lower in HCC patients when compared to cirrhotic patients without HCC or control group [p<0.0001]. Significant decrease of serum TTR in HCC patients, with portal vein invasion or nodal invasion than in HCC without vascular or nodal invasion. The diagnostic accuracy of TTR was higher than that of AFP regarding sensitivity [83.3%] and negative predictive value [81.4%] in diagnosis of HCC.
Conclusion: detection of lower level of TTR alone or in combination with other validated markers may be potentially informative biomarker for detection of HCC among cirrhotic patients at early noninvasive stage where curative treatment can be applied. 

DOI

10.21608/ijma.2020.23373.1094

Keywords

TTransthyretin, Cirrhosis, Hepatocellular carcinoma, alpha-fetoprotein, Noninvasive

Authors

First Name

Magda

Last Name

Ibrahim

MiddleName

Hussin

Affiliation

Department of Physiology (Zoology), Faculty of Science, Damietta University, Egypt

Email

magdahussin2014@gmail.com

City

-

Orcid

-

First Name

Fathiya

Last Name

El-Raey

MiddleName

Mostafa

Affiliation

Department of Hepatogastroenterology and Infectious Diseases, Damietta Faculty of Medicine, Al-Azhar University, Egypt

Email

faresmd76@yahoo.com

City

Damietta

Orcid

-

First Name

Naglaa

Last Name

Fathy

MiddleName

-

Affiliation

Department of Zoology (Physiology), Faculty of Scicene, Damietta University, Egypt

Email

elarabny@gmail.com

City

-

Orcid

-

First Name

Kadrey

Last Name

El-Bakrey

MiddleName

-

Affiliation

Department of Zoology (physiology) Faculty of science, Damietta University, Egypt

Email

kelbakry2003@yahoo.com

City

-

Orcid

-

Volume

2

Article Issue

2

Related Issue

13522

Issue Date

2020-04-01

Receive Date

2020-02-02

Publish Date

2020-04-01

Page Start

412

Page End

419

Print ISSN

2636-4174

Online ISSN

2682-3780

Link

https://ijma.journals.ekb.eg/article_82380.html

Detail API

https://ijma.journals.ekb.eg/service?article_code=82380

Order

12

Type

Original Article

Type Code

816

Publication Type

Journal

Publication Title

International Journal of Medical Arts

Publication Link

https://ijma.journals.ekb.eg/

MainTitle

Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients

Details

Type

Article

Created At

22 Jan 2023